13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001825034
Total reported value
$439.8M
$439.8M
12 檔
80.9%
The Q4 2025 SEC filing reveals that Euclidean Capital LLC held a total portfolio value of $439.8M, covering 12 public equity positions.
In Q4 2025, Euclidean Capital LLC displayed an active expansion posture, initiating 1 new positions and adding to 1 existing holdings, outstripping position reductions.
In terms of portfolio concentration, the top 5 core holdings (including VEU, VTV, INDA) accounted for 80.9% of total reported equity market value during Q4 2025.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | VEU | Vanguard Ftse All-world Ex-u | ETF-Other | 59.53% | -0.33% | +15.98% | |
| 2 | VTV | Vanguard Value ETF | ETF-Other | 26.88% | -0.25% | — | |
| 3 | INDA | Ishares Msci India ETF | ETF-Other | 5.41% | -0.26% | — | |
| 4 | FHTX | Foghorn Therapeutics Inc | Stock-Other | 2.30% | -0.17% | — | |
| 5 | ORIC | Oric Pharmaceuticals Inc | Stock-Other | 2.19% | -0.76% | — | |
| 6 | PMVP | Pmv Pharmaceuticals Inc | Stock-Other | 0.89% | -0.03% | — | |
| 7 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 0.76% | — | — | |
| 8 | RAPT | Rapt Therapeutics Inc | Stock-Other | 0.75% | — | — | |
| 9 | ALEC | Alector Inc | Stock-Other | 0.55% | -0.12% | — | |
| 10 | SRZN | Surrozen Inc | Stock-Other | 0.54% | -0.13% | — | |
| 11 | TNYA | Tenaya Therapeutics Inc | Stock-Other | 0.20% | -0.01% | — | |
| 12 | SRZNW | Surrozen Inc-cw25 | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SRZN | Surrozen Inc | +0.1% | — | Unchanged |
| 2 | SRZNW | Surrozen Inc-cw25 | — | — | Unchanged |
| 3 | RAPT | Rapt Therapeutics Inc | -0.1% | — | Unchanged |
| 4 | SPY | Ss Spdr S&p 500 ETF Trust-us | -0.4% | — | Unchanged |
| 5 | TNYA | Tenaya Therapeutics Inc | -0.5% | — | Unchanged |
| 6 | PMVP | Pmv Pharmaceuticals Inc | -0.7% | — | Unchanged |
| 7 | FHTX | Foghorn Therapeutics Inc | -0.9% | — | Unchanged |
| 8 | ALEC | Alector Inc | -1.1% | — | Unchanged |
| 9 | INDA | Ishares Msci India ETF | -2.7% | — | Unchanged |
| 10 | ORIC | Oric Pharmaceuticals Inc | -2.8% | — | Unchanged |
| 11 | VEU | Vanguard Ftse All-world Ex-u | -17.8% | +15.98% | Add |
| 12 | VTV | Vanguard Value ETF | — | NEW | New buy |
According to official SEC Form 13F filings, Euclidean Capital LLC reported a total U.S. public equity portfolio value of $439.8M across 12 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
VTV
市值: $99.3M
During Q4 2025, Euclidean Capital LLC's top holdings by market value included VEU (59.5%)、VTV (26.9%)、INDA (5.4%). The largest single position, VEU, represented 59.5% of total portfolio value.
In Q4 2025, Euclidean Capital LLC made 2 total portfolio adjustments, initiating 1 new buys, adding to 1 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.